Get my own profile
Public access
View all138 articles
25 articles
available
not available
Based on funding mandates
Co-authors
robert c. glenCambridge University and Imperial College LondonVerified email at cam.ac.uk
Jeremy L. JenkinsUS Head Discovery Sciences, Novartis Institutes for BioMedical ResearchVerified email at novartis.com
Isidro Cortés CirianoEMBL-EBIVerified email at ebi.ac.uk
Meir GlickDirector, Structural Chemistry, Merck & CoVerified email at merck.com
Prof. Gerard JP van WestenPI Computational Drug Discovery (Professor AI & Med Chem, Leiden University)Verified email at gjpvanwesten.nl
Julian FuchsBoehringer IngelheimVerified email at boehringer-ingelheim.com
Josef ScheiberManaging Director at BioVariance GmbHVerified email at josef-scheiber.de
Lewis MervinAstraZenecaVerified email at astrazeneca.com
Alexios KoutsoukasBristol Myers SquibbVerified email at bms.com
Herman van VlijmenHead, Computational ChemistryVerified email at its.jnj.com
Therese MalliavinLaboratoire de Physique et Chimie ThéoriquesVerified email at univ-lorraine.fr
David R SpringUniversity of CambridgeVerified email at ch.cam.ac.uk
Jörg Kurt WegnerAssociate Scientific Director, Team Lead AI Design Team, Janssen R&D, Cambridge, MA, USVerified email at its.jnj.com
Ola EngkvistAstraZeneca R&D Gothenburg Orcid:0000-0003-4970-6461Verified email at astrazeneca.com
Eelke van der HorstThe HyveVerified email at thehyve.nl
Dr.Gautam SethiNational University of SingaporeVerified email at nus.edu.sg
Steven WhitebreadRetiredVerified email at one-name.org
Fredrik SvenssonCancer Research HorizonsVerified email at cancer.org.uk
Georgios DrakakisPost Doctoral Research AssociateVerified email at cam.ac.uk
Dezső MódosQuadram Institute BioscienceVerified email at quadram.ac.uk